Clinical and Biological Characteristics of Hidradenitis Suppurativa
Recruiting
- Conditions
- Hidradenitis Suppurativa
- Registration Number
- NCT03967600
- Lead Sponsor
- University of California, San Francisco
- Brief Summary
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
- Age 13 years or older
- Diagnosis of HS clinically-confirmed by a physician
Read More
Exclusion Criteria
- Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.
Healthy Volunteer
Inclusion Criteria:
- No history of chronic skin conditions
- No recent history of antibiotic use
Exclusion Criteria:
- Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary aim of this study is to identify clinical and biologic characteristics of hidradenitis suppurativa. 2016-2026
- Secondary Outcome Measures
Name Time Method Secondary aims include correlating alterations in clinical and biological characteristics with disease status, and identifying genetic variants that predict disease progression or response to therapy. 2016-2026
Trial Locations
- Locations (1)
University of California, San Francisco
🇺🇸San Francisco, California, United States